What will digital health M&A look like in 2022?
After a busy year for digital health, four experts shared their predictions on which sectors will see the most M&A, and which companies are likely to get together in the future.
presented by
Insurers paid out $2B in rebates for last year’s claims
Insurers that didn’t meet medical loss ratio requirements have paid out a total of $2 billion in rebates to nearly 10 million people, split between people who received their insurance through individual market plans and group plans.
presented by
When Investment Rhymes with Canada
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
GE Healthcare closes $1.45B acquisition of BK Medical
The company would become part of GE’s ultrasound business, expanding its capabilities to include surgical visualization. GE plans to spin out its healthcare division into a publicly traded company in 2023.
presented by
Oracle to buy Cerner for $28.3B
The companies struck an all-cash deal on Monday for $95-per share. Oracle plans to add a voice interface to Cerner’s electronic health record system.
Digital health funding smashed another record this year, but is the trend sustainable?
Digital health companies have now raised more than $20 billion in 2021, more than any other year. While experts expect to see the dealmaking continue, they raised caution about the challenges of going public with high valuations.
Cerner stock rises on potential $30B sale to Oracle
Oracle is reportedly in talks to buy Cerner for $30 billion, according to the Wall Street Journal. If it closes, it would be the largest health tech deal this year.
Humana, Centene file antitrust suit against Gilead for HIV drug agreements
The insurers referred to deals Gilead struck with Janssen, Bristol Myers Squibb to prevent the generic version of its retroviral medications from being used as part of combination treatments. They also allege the company struck a deal with Teva to delay the release of its generic drug.
Medtronic hit with FDA warning letter for diabetes devices
The company received a warning letter on Wednesday related to inadequate quality requirements at the headquarters for its diabetes business. It comes after Medtronic expanded a recall of its MiniMed 600 series insulin pumps.
Flume looks to build behind-the-scenes framework for health plans
The startup is looking to help launch health plans by handling some of the administrative components. It bills itself as a tech-forward third-party administrator, and can help manage claims and enrollment.
Innovaccer valued at $3.2B in most recent fundraise
The company, which is building a cloud-based platform to help health systems pull health records together, recently closed a $150 million funding round.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Appeals court declines to reinstate CMS’ vaccine mandate
A panel of judges on the 8th Circuit Court of Appeals declined to reinstate a vaccine mandate for healthcare workers that was set to go into effect in January. A federal judge had blocked the mandate last month from the Centers for Medicare and Medicaid Services after 10 states filed suit.
Provider groups sue as surprise billing enforcement nears
The American Medical Association, American Hospital Association and other provider groups are suing the Department of Health and Human Services over a small but important detail of how it is implementing surprise billing legislation. They argue that the arbitration process for unresolved disputes currently favors insurers.
Survey: Telehealth users skew young, wealthy
According to Rock Health’s annual consumer adoption survey, telehealth users tend to be higher income, younger and live in urban areas. The survey also tracked people’s satisfaction with telehealth and what modalities people used most to access care.
Philips gets FDA clearance for two acute patient monitors
The FDA granted 510(k) clearance to two of Philips’ newest acute care patients monitors, the IntelliVue MX750 and MX850. A year ago, the company had gotten an emergency use authorization for its monitors.
Cigna invests in Bright Health’s $750M financing
Cigna Ventures and Bright's majority shareholder, New Enterprise Associates, are contributing to the financing. It comes as Bright faces higher-than-expected medical costs during the pandemic.